| scholarly article | Q13442814 |
| P50 | author | Donald E Low | Q60650638 |
| Keith P. Klugman | Q79427702 | ||
| Richard G Wise | Q87084887 | ||
| P2093 | author name string | David Hooper | |
| Patrice Courvalin | |||
| Lance R Peterson | |||
| Lionel A Mandell | |||
| Urs B Schaad | |||
| P2860 | cites work | Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria | Q24564231 |
| Comparative double-blind study of 200- and 400-mg enoxacin given orally in the treatment of acute uncomplicated urethral gonorrhea in males | Q24678414 | ||
| Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
| Comparative tolerability of the newer fluoroquinolone antibacterials | Q28146268 | ||
| Structure-activity and structure-side-effect relationships for the quinolone antibacterials | Q28246405 | ||
| Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones. | Q30329277 | ||
| Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study | Q32068605 | ||
| Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible | Q33747123 | ||
| Ciprofloxacin in treatment of nosocomial meningitis in neonates and in infants: report of 12 cases and review. | Q33756171 | ||
| New uses for new and old quinolones and the challenge of resistance | Q33835830 | ||
| Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group | Q33926761 | ||
| Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network | Q33972906 | ||
| Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae | Q34319265 | ||
| Minimizing potential resistance: the molecular view | Q34347856 | ||
| Fluoroquinolone antimicrobial agents | Q34613302 | ||
| The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance | Q34962080 | ||
| Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy | Q35245733 | ||
| Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin | Q35536186 | ||
| Epidemiology of drug resistance: implications for a post-antimicrobial era | Q35748958 | ||
| Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study | Q36599754 | ||
| Analysis of multiply antimicrobial-resistant isolates of Streptococcus pneumoniae from the United States | Q36757780 | ||
| Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort study | Q37091689 | ||
| Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria | Q37416742 | ||
| Ciprofloxacin in neonatal Enterobacter cloacae septicaemia | Q38364749 | ||
| Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin | Q38957462 | ||
| Emergence of Multiply Resistant Pneumococci | Q39209668 | ||
| Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults | Q39260345 | ||
| The biopesticide Paenibacillus popilliae has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster | Q39473189 | ||
| A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux. | Q39473327 | ||
| Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae | Q39473366 | ||
| Carriage of respiratory tract pathogens and molecular epidemiology of Streptococcus pneumoniae colonization in healthy children attending day care centers in Lisbon, Portugal. | Q39508225 | ||
| A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone | Q39871861 | ||
| Toxicity of quinolone antimicrobial agents | Q40526656 | ||
| Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients | Q40659543 | ||
| Tolerability of fluoroquinolone antibiotics. Past, present and future | Q40964316 | ||
| Pathogenesis of bacterial bronchitis in cystic fibrosis | Q41322185 | ||
| Quinolone arthropathy in animals versus children | Q41663884 | ||
| Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin | Q43508711 | ||
| Macrolide resistance among invasive Streptococcus pneumoniae isolates | Q43763972 | ||
| Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. | Q43778960 | ||
| Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia | Q44967556 | ||
| Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high human immunodeficiency virus seroprevalence | Q45037317 | ||
| Histologic and histochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone | Q46601415 | ||
| Oral ciprofloxacin vs. intravenous ceftazidime plus tobramycin in pediatric cystic fibrosis patients: comparison of antipseudomonas efficacy and assessment of safety with ultrasonography and magnetic resonance imaging. Cystic Fibrosis Study Group | Q46658825 | ||
| Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae | Q48106945 | ||
| Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children | Q50118143 | ||
| Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel | Q50897569 | ||
| Failure of treatment of pneumonia associated with highly resistant pneumococci in a child. | Q54079932 | ||
| Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. | Q54086013 | ||
| Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. | Q54102176 | ||
| Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. | Q54106765 | ||
| An Enzyme from Bacteria able to Destroy Penicillin | Q54138191 | ||
| Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland. | Q54139298 | ||
| Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. | Q54152223 | ||
| Transposable multiple antibiotic resistance in Streptococcus pneumoniae. | Q54420551 | ||
| Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae | Q57830846 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic resistance | Q380775 |
| P304 | page(s) | 721-727 | |
| P577 | publication date | 2002-08-20 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? | |
| P478 | volume | 35 |
| Q34146995 | A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India. |
| Q50796828 | A one-year prospective study on the antibiotic resistance of E. coli strains isolated in urinary specimens of children hospitalized at the University Pediatric Medical Center in Novi Sad, Serbia |
| Q24798440 | Activity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitis |
| Q35895935 | Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong |
| Q34764110 | Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study |
| Q35547236 | Fluoroquinolone AUIC Break Points and the Link to Bacterial Killing Rates Part 2: Human Trials |
| Q35880906 | Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001 |
| Q34807455 | Fluoroquinolone resistance among Gram-positive cocci |
| Q35211282 | Fluoroquinolones in paediatrics: a risk for the patient or for the community? |
| Q35964560 | Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC. |
| Q81679199 | Gatifloxacin Therapy in Otitis Media in Children |
| Q48202873 | History of antibiotics: from fluoroquinolones to daptomycin (Part 2). |
| Q37284961 | Infectious diseases and vaccine sciences: strategic directions |
| Q35917230 | Levofloxacin: update and perspectives on one of the original 'respiratory quinolones'. |
| Q37191555 | Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa |
| Q42112596 | Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread |
| Q44678028 | Multicentre study of the molecular epidemiology, serotypes and antimicrobial susceptibility patterns of invasive Streptococcus pneumoniae invasive isolated from children in the Ille de France area |
| Q73255558 | New quinolones |
| Q39865981 | Off-label antibiotic use in children in three European countries |
| Q35692693 | Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance |
| Q36022938 | Overcoming current obstacles in the management of bacterial community-acquired pneumonia in ambulatory children |
| Q39245829 | Prevalence and nature of off-label antibiotic prescribing for children in a tertiary setting: A descriptive study from Jordan. |
| Q80497008 | Resolution of ofloxacin-ciprofloxacin and ofloxacin-norfloxacin binary mixtures by flow-injection chemiluminescence in combination with partial least squares multivariate calibration |
| Q38728987 | Safety Concerns Surrounding Quinolone Use in Children |
| Q36571957 | Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration. |
| Q39755545 | Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States |
Search more.